Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDV Booster in Healthy Adolescents and Adults
NCT03999996Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2019
- Primary completion
- May 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of dengue tetravalent vaccine, live, attenuated in dengue fever, sponsored by Takeda. Started Nov 2019; status: completed.
02
Drugs
dengue tetravalent vaccine, live, attenuated
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT03999996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999996.